Title
Category
Credits
Event date
Cost
Acute Bacterial Rhinosinusitis: When Is It Ok To Use Antibiotics?
  • Pharmacology
  • Sinusitis
  • 0.65 AANP Contact Hours
  • 0.65 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
In this 30-minute podcast tailored for medical professionals, navigate the nuances of Acute Bacterial Rhinosinusitis (ABRS) as expert faculty discuss differentiating symptoms from acute rhinosinusitis. Gain practical insights on constructing effective treatment plans for ABRS in adults and acute bacterial sinusitis in pediatric populations, offering valuable guidance for appropriate antibiotic use in these scenarios. Stay informed and enhance your clinical decision-making skills in managing these common conditions.
Mind Over Memory: New Treatment Options for Alzheimer Disease
  • Pharmacology
  • 0.48 AANP Contact Hours
  • 0.48 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD.
Opioids and Opioid Use Disorder: A Case-Based Approach to Manage Pain During The Opioid Epidemic
  • Opioid Use Disorder (OUD)
  • Pharmacology
  • 0.77 AANP Contact Hours
  • 0.77 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit™
$0.00
Immerse yourself in a case-based exploration of the complex landscape surrounding opioids and opioid use disorder. In this podcast, you will explore guideline recommendations for safe opioid prescribing, gain insights into diagnosing opioid use disorder, and understand the essential indications for buprenorphine in OUD. Acquire practical knowledge to navigate pain management challenges amidst the opioid epidemic, fostering responsible practices in patient care.